Aaron Hansen
Princess Alexandra Hospital · University Health Network, Toronto · University Health Network, Toronto, ON, Canada
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aaron Hansen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:11 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05720130 · Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).AdvanCell Pty Limited · recruiting · Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer · principal investigator
- N/ANCT05248425 · Study to Measure and Enhance the Health Related Quality Of Life in Cancer PatientsUniversity Health Network, Toronto · withdrawn · Cancer · principal investigator
- Ph2NCT03385655 · Prostate Cancer Biomarker Enrichment and Treatment SelectionCanadian Cancer Trials Group · active not recruiting · Prostate Cancer · study chair
- Ph1NCT02537223 · Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck CancerUniversity Health Network, Toronto · completed · Squamous Cell Carcinoma of Head and Neck, Locoregionally Advanced · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:11 UTC. The ranking covers the 200 most relevant of 226 PubMed records, and a shared surname and initials can bring in a namesake. All 226 on PubMed
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.J Clin Oncol · 20202,449 citationsRCR 111.1
- Inhibition of insulin secretion by somatostatin.Lancet · 1973573 citationsRCR 18.0
- Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.J Clin Oncol · 2022428 citationsRCR 28.3
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.J Clin Oncol · 2017382 citationsRCR 11.9
- 238 citationsRCR 7.7
- Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.Genome Med · 2016213 citationsRCR 5.4
- Skeletal muscle adaptation: training twice every second day vs. training once daily.J Appl Physiol (1985) · 2005182 citationsRCR 5.6
- Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases.Eur J Clin Nutr · 2000173 citationsRCR 4.6
- 163 citationsRCR 17.1
- The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial.Clin Infect Dis · 2015153 citationsRCR 4.3